Liquid Oxygen Devices Market Size & Growth Forecast 2027–2036, By Segments (End-use), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Liquid Oxygen Devices Market size was valued at USD 1.9 billion in 2026 and is projected to grow at a 5.51% CAGR from 2027 to 2036, reaching USD 3.25 billion by 2036. The industry revenue for 2027 is estimated at USD 1.99 billion.
Get more details on this report
Request Free Sample ReportLiquid Oxygen Devices Market Intelligence Snapshot
Regional Market Dynamics
- North America leads with largest share in 2026 due to strong healthcare infrastructure, mature reimbursement systems, and steady demand for long-term respiratory oxygen therapy.
- Asia Pacific grows at 4.9% CAGR driven by expanding healthcare access, rising respiratory disease treatment, and broader adoption of hospital and home-based oxygen therapy.
Segment Momentum
- Homecare Settings accounted for 48.77% of the market in 2026 due to their central role in long-term oxygen therapy, offering continuous oxygen access, greater convenience, and reduced reliance on facility-based care.
- Growth is supported by patient preference for mobility, routine disease management at home, and fewer institutional visits, allowing home-based treatment to expand from an already established position.
Market Expansion Drivers
- Rising prevalence of chronic respiratory disorders increasing long-term oxygen therapy demand.
- Advancements in portable and lightweight oxygen concentrators improving homecare patient mobility.
- Government-backed medical oxygen infrastructure expansion strengthening liquid oxygen device deployment.
Leading Market Participants
- Key players in the liquid oxygen devices market include CAIRE Inc. (United States), CRYOFAB, Inc. (United States), Koninklijke Philips N.V. (Netherlands), Air Liquide S.A. (France), Chart Industries, Inc. (United States), Linde plc (Ireland), Messer Group GmbH (Germany), Invacare Corporation (United States), Precision Medical, Inc. (United States).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 1.9 billion
- 2027 Estimated Market Size: USD 1.99 billion.
- Projected Market Size: USD 3.25 billion by 2036
- Growth Forecast: 5.51% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Homecare Settings (End-use)
- Emerging Opportunity Segment: Homecare Settings (End-use)
Market Growth Drivers and Industry Trends
Rising prevalence of chronic respiratory disorders increasing long-term oxygen therapy demand
The growing burden of chronic respiratory conditions will drive the liquid oxygen devices market growth as more patients require sustained supplemental oxygen to manage impaired respiratory function. Conditions associated with persistent oxygen deficiency can necessitate long-term oxygen therapy across homecare and clinical environments, increasing the need for dependable oxygen delivery systems. Liquid oxygen solutions can support extended therapy by enabling efficient oxygen storage and delivery for patients who require continuous supplementation, particularly those managing treatment outside hospitals. Rising demand for home-based respiratory care is also encouraging healthcare providers and caregivers to prioritize oxygen systems that can support regular therapy while accommodating patients' daily routines.
Advancements in portable and lightweight oxygen concentrators improving homecare patient mobility
Technological improvements in portable oxygen delivery are expanding the usability of respiratory support outside traditional healthcare settings, supporting the liquid oxygen devices market through greater emphasis on patient mobility. Lightweight and compact oxygen systems allow patients receiving long-term therapy to move more freely within and beyond their homes without being as dependent on stationary equipment. Improvements in device ergonomics, energy efficiency, and oxygen delivery mechanisms are also making home oxygen therapy more manageable for patients and caregivers. These developments are particularly relevant for individuals seeking to maintain daily activities while continuing prescribed oxygen treatment, increasing interest in convenient and transportable respiratory support solutions.
Government-backed medical oxygen infrastructure expansion strengthening liquid oxygen device deployment
Government investment in medical oxygen infrastructure is strengthening healthcare systems' capacity to store, distribute, and deliver oxygen across hospitals, emergency facilities, and community healthcare settings. Such programs will propel the liquid oxygen devices market growth by improving access to oxygen supplies and supporting the development of infrastructure capable of handling different oxygen delivery requirements. Public healthcare initiatives focused on strengthening medical preparedness can encourage facilities to upgrade storage and distribution capabilities, particularly where reliable oxygen availability is essential for respiratory care. Expansion of centralized oxygen infrastructure also supports deployment of compatible equipment for controlled delivery and management of liquid oxygen within healthcare environments.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising prevalence of chronic respiratory disorders increasing long-term oxygen therapy demand | 1.90% | Moderate | North America, Europe | High | Near Term |
| Advancements in portable and lightweight oxygen concentrators improving homecare patient mobility | 1.60% | Moderate | Asia Pacific, North America | High | Mid Term |
| Government-backed medical oxygen infrastructure expansion strengthening liquid oxygen device deployment | 1.20% | High | Asia Pacific, Middle East & Africa | Emerging | Long Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
North America held the largest share of the liquid oxygen devices market in 2026, supported by advanced respiratory care infrastructure, established home healthcare networks, and strong demand for oxygen therapy among patients requiring long-term respiratory support. The region benefits from widespread availability of portable oxygen technologies, sophisticated healthcare delivery systems, and favorable reimbursement environments that facilitate access to respiratory equipment. Growing adoption of home-based care and increasing emphasis on improving patient mobility are also supporting demand for liquid oxygen devices.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is positioned as the fastest-growing region, driven by expanding healthcare infrastructure, rising awareness of respiratory disease management, and improving access to oxygen therapy technologies. Increasing healthcare investments and the development of homecare services are creating broader opportunities for portable and efficient oxygen delivery systems. Greater attention to respiratory care capacity and the modernization of medical equipment across emerging healthcare markets are further strengthening regional adoption.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Clinical Respiratory PrecisionGermany focuses on high-quality liquid oxygen devices that support hospital respiratory care and structured long-term oxygen therapy programs. The country continues to value equipment durability, regulatory compliance, and efficient integration into established pulmonary care pathways.
France 🇫🇷
Community Care ContinuityFrance strengthens the use of liquid oxygen devices through established community healthcare networks supporting long-term respiratory patients. France prioritizes dependable oxygen delivery solutions that enhance treatment adherence while reducing unnecessary hospital-based respiratory care.
Italy 🇮🇹
Pulmonary Therapy AccessItaly continues expanding access to liquid oxygen devices for chronic respiratory disease management across hospital and homecare settings. Italian healthcare providers value practical oxygen delivery systems that simplify patient mobility while supporting consistent long-term treatment.
Japan 🇯🇵
Aging Care SupportJapan relies on liquid oxygen devices to address respiratory care needs associated with its aging population and long-term disease management. Healthcare providers increasingly seek compact systems that improve patient convenience while supporting consistent oxygen delivery outside acute care facilities.
South Korea 🇰🇷
Connected Respiratory ServicesSouth Korea encourages adoption of liquid oxygen devices alongside digitally supported respiratory care services and expanding home treatment models. The country places growing emphasis on efficient patient monitoring, device usability, and continuity of oxygen therapy beyond hospital environments.
United States 🇺🇸
Homecare Oxygen IntegrationThe U.S. liquid oxygen devices market emphasizes portable oxygen therapy and integrated homecare services for patients with chronic respiratory conditions. Healthcare providers increasingly prioritize equipment reliability, patient mobility, and coordinated oxygen supply management across clinical and residential settings.
Segment Leadership and Growth Trends
Liquid Oxygen Devices Market Share (%), by End-use, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportEnd-use Segment Analysis: Homecare Settings (Largest & Fastest-Growing Segment)
Homecare settings dominated the end-use segment of the liquid oxygen devices market, accounting for a 48.77% share in 2026, while also representing the fastest-growing segment. Its strong position reflects the increasing preference for managing long-term oxygen requirements outside traditional hospital environments, allowing patients to receive respiratory support in familiar surroundings. Home-based oxygen therapy can improve convenience and reduce dependence on repeated hospital visits, particularly for patients requiring ongoing respiratory assistance. Growing emphasis on patient-centered care, decentralized treatment, and home-based healthcare delivery is further strengthening demand for liquid oxygen devices in homecare settings.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| End-use | Hospitals, Homecare Settings, Ambulatory Surgical Centers, Others | Homecare Settings | Homecare Settings |
Competitive Landscape and Market Positioning
Top players in the liquid oxygen devices market:
1. CAIRE Inc. (United States)
2. CRYOFAB Inc. (United States)
3. Koninklijke Philips N.V. (Netherlands)
4. Air Liquide S.A. (France)
5. Chart Industries Inc. (United States)
6. Linde plc (Ireland)
7. Messer Group GmbH (Germany)
8. Invacare Corporation (United States)
9. Precision Medical Inc. (United States)
The liquid oxygen devices market is experiencing technological improvements focused on portability, energy efficiency, and patient mobility. Companies are introducing compact oxygen delivery systems designed to support long-term respiratory care and home healthcare applications. Expanding healthcare infrastructure and growing emphasis on patient-centered respiratory management are also supporting broader deployment of advanced liquid oxygen technologies.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| CAIRE Inc. (United States) | |||||||
| CRYOFAB Inc. (United States) | |||||||
| Koninklijke Philips N.V. (Netherlands) | |||||||
| Air Liquide S.A. (France) | |||||||
| Chart Industries Inc. (United States) | |||||||
| Linde plc (Ireland) | |||||||
| Messer Group GmbH (Germany) | |||||||
| Invacare Corporation (United States) | |||||||
| Precision Medical Inc. (United States). |
Industry Development/News
| Company Name | Date | Key Development |
|---|
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Liquid Oxygen Devices Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Device Type | Liquid Oxygen Systems, Portable Liquid Oxygen Units, Stationary Liquid Oxygen Units, Liquid Oxygen Reservoirs |
| Mobility | Stationary Use, Portable Use, Ambulatory Use |
| Distribution Channel | Direct Sales, Medical Equipment Distributors, Specialty Respiratory Care Providers, Online Channels |
Liquid Oxygen Devices Market — Custom TOC
| Custom Chapter | Custom Details |
|---|---|
| Home Oxygen Therapy Adoption Assessment |
|
| Distribution Channel Transformation Analysis |
|
| Reimbursement and Payer Coverage Landscape |
|
Need a different cut of the data?
Request Custom ResearchWhat is the current revenue of the liquid oxygen devices market?
What are the growth projections for the liquid oxygen devices industry?
How is the rising burden of chronic respiratory disorders reshaping demand and purchasing behavior in the liquid oxygen devices market?
Why is government-led oxygen infrastructure expansion becoming strategically important for liquid oxygen device deployment?
Why do Homecare Settings lead the liquid oxygen devices market?
What is driving growth in Homecare Settings within the liquid oxygen devices market?
Why does North America lead the liquid oxygen devices market?
What is driving Asia Pacific growth in liquid oxygen devices?
Which companies are driving growth in the liquid oxygen devices landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source | Reference |
|---|---|
| World Health Organization (WHO) | www.who.int |
| U.S. Food & Drug Administration (FDA) | www.fda.gov |
| European Medicines Agency (EMA) | www.ema.europa.eu |
| Centers for Disease Control and Prevention (CDC) | www.cdc.gov |
| National Institutes of Health (NIH) | www.nih.gov |
| National Center for Biotechnology Information (NCBI) | www.ncbi.nlm.nih.gov |
| PubMed | pubmed.ncbi.nlm.nih.gov |
| ClinicalTrials.gov | clinicaltrials.gov |
| International Organization for Standardization (ISO) | www.iso.org |
| ASTM International | www.astm.org |
| Advanced Medical Technology Association (AdvaMed) | www.advamed.org |
| Medical Device Innovation Consortium (MDIC) | mdic.org |
| Biotechnology Innovation Organization (BIO) | www.bio.org |
| International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | www.ifpma.org |
| U.S. Pharmacopeia (USP) | www.usp.org |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | www.edqm.eu |
| World Organisation for Animal Health (WOAH) | www.woah.org |
| American Hospital Association (AHA) | www.aha.org |
| OECD Health | www.oecd.org/health |
| World Bank Data | data.worldbank.org |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization